Printer Friendly Version View printer-friendly version
<< Back
Kite to Present at June 2017 Investor Conferences
Download PDF Download PDF

SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc., (Nasdaq:KITE), a leading cell therapy company, today announced that management will present at two investor conferences in June 2017:

  • Jefferies 2017 Global Healthcare Conference
    Wednesday, June 7
    1:30pm Eastern Time
    New York, NY
  • Goldman Sachs 38th Annual Global Healthcare Conference
    Tuesday, June 13
    2:00pm Pacific Time
    Rancho Palos Verdes, CA

A live audio webcast of each event will be available on the Investors section of Kite's website, www.kitepharma.com. A replay of each webcast will be available on the website for approximately 30 days.

About Kite

Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information on Kite, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

Kite
Christine Cassiano
SVP, Corporate Communications & Investor Relations
ccassiano@kitepharma.com
or
Greg Mann
VP, Investor Relations
gmann@kitepharma.com

Source: Kite Pharma, Inc.

News Provided by Acquire Media

NASDAQ (US Dollar)
$71.62
 Stock is Up 0.16 (0.22%)
Data as of 06/21/18 1:30 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Gilead Sciences at the Goldman Sachs 39th Annual Global Healthcare Conference

June 13, 2018 8:40 a.m. PT
Play
Gilead Sciences at Jefferies 2018 Global Healthcare Conference

June 06, 2018 10:30 a.m. ET
Play
Gilead Sciences at the Bank of America Merrill Lynch Healthcare Conference

May 16, 2018 9:20 a.m. PT
Play
2018 Annual Meeting of Stockholders

May 09, 2018 10:00 a.m. PT
Play